Stock Trading CanaryHONG KONG · DIRECTORS' NOTICES
Antengene Corporation Ltd. - B
06996 · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by a director in the last 180 days.
Price vs insider buying
6996.HK · HKD● Purchase × Sale ◇ Public disclosure ▥ 15-day cluster ·
Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.
Insiders' buying price vs the latest close
Insiders paid 4.01 HKD a share on average (2 purchase lines, 1 buyer, 2026-03-23 – 2026-03-24). The close on 2026-11-05 was 26.4% below that price.
The latest purchase (2026-03-24) was at 4.14 HKD; the close was 28.7% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored. 2 more purchase lines could not be compared with the share price and are left out.
Director trades on the exchange
Purchases and sales on the exchange in the last 12 months, as counted in the score.
| Trade date | Filed | Director | Held as | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-03-24 | 2026-03-24 | Mei Jay | Controlled company | Bought | 100,000 | HK$0.523 | HK$52.3K |
| 2026-03-24 | 2026-03-24 | Lung Donald Andrew | Own name | Bought | 235,000 | HK$4.14 | HK$972.0K |
| 2026-03-23 | 2026-03-24 | Lung Donald Andrew | Own name | Bought | 267,500 | HK$3.89 | HK$1.0M |
| 2026-03-23 | 2026-03-24 | Mei Jay | Controlled company | Bought | 100,000 | HK$0.501 | HK$50.1K |
| 2025-11-17 | 2025-12-10 | Fonseca Rafael | — | Sold | 50,000 | HK$4.70 | HK$235.0K |